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Abstract
Transhydrogenase from mitochondrial and bacterial membranes couples proton translocation to hydride transfer between
 .  .NAD H and NADP H . The enzyme has three domains, of which domains I and III protrude from the membrane. These
 .  .possess the NAD H - and NADP H -binding sites, respectively, whereas domain II spans the membrane. In domain I there
 .is a mobile loop which emanates from the surface of the protein, but which closes down upon NAD H binding. In this
 .report we show that the NADP H -dependent reduction of acetylpyridine adenine dinucleotide by NADH catalysed by
Rhodospirillum rubrum transhydrogenase has ‘ping-pong’ kinetics, confirming that the reaction is cyclic. We then describe
the kinetic and thermodynamic properties of mutants of recombinant domain I protein from the R. rubrum enzyme, in
 .  .which Tyr-235 in the mobile loop has been substituted with Phe or Asn residues dI.Y235F and dI.Y235N, respectively . 1
Equilibrium dialysis measurements show that dI.Y235F and dI.Y235N bind NADH more weakly than wild-type domain I
 .  .  .protein the K increases twofold and fourfold, respectively . 2 Reverse transhydrogenation rates in steady state ofd
domain I-depleted membrane vesicles reconstituted with either dI.Y235F or dI.Y235N are inhibited by about 50% and 78%,
 .respectively, relative to those obtained in reconstitutions with wild-type domain I protein. 3 Reverse transhydrogenation
 .rates in steady state of mixtures of recombinant domain III protein and either dI.Y235F or dI.Y235N are inhibited only by
 .about 10% and 20%, respectively, relative to those obtained in mixtures with wild-type protein. 4 Forward transhydro-
 .genation rates in both the complete enzyme and in domain I:III complexes are inhibited even less by the mutations than
 .  .  .  .the reverse reactions. 5 In contrast with 1 , 2 and 3 , cyclic transhydrogenation was strongly inhibited in both the
reconstituted membrane system and in the recombinant domain I:III complexes only 7–8% activity remains with dI.Y235F,
.and only 2–3% with dI.Y235N . It was recently established that, in contrast to forward and reverse transhydrogenation, the
cyclic reaction is substantially limited by the rate of hydride transfer. It is therefore concluded that mutations at Tyr-235 in
the mobile loop severely disrupt the hydride transfer step in the catalytic reaction of transhydrogenase.
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Abbreviations: AcPdADq, acetylpyridine adenine dinucleotide
) Corresponding author. Fax: q44 121 414 3982; E-mail: j.b.jackson@bham.ac.uk
0005-2728r97r$17.00 Copyright q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0005-2728 97 00030-3
( )T. Bizouarn et al.rBiochimica et Biophysica Acta 1320 1997 265–274266
1. Introduction
Transhydrogenase, an enzyme found in the inner
membrane of animal mitochondria and the cytoplas-
mic membrane of bacteria, seems to be unique as a
proton pump because the standard free energy of its
chemical reaction is close to zero:
NADHqNADPqqHq mNADqqNADPHqHqout in
1 .
In vivo the reaction is driven from left to right by
the free energy of the proton electrochemical gradient
 .D p generated by the action of respiratory or photo-
synthetic electron transport chains. The function of
the enzyme is not known definitively, although a
number of possibilities have been discussed re-
w x.viewed 1 . Perhaps the most plausible role for mito-
chondrial transhydrogenase is that it provides a con-
trolling link between D p and flux through the tricar-
w xboxylic acid cycle 1 , while in bacteria it probably
w xsupplies NADPH for amino acid biosynthesis 2 and
for the reduction of glutathione in methanol
w xmetabolism 3 .
The enzyme has three domains. Domains I and III
protrude from the membrane on the matrix side in
.mitochondria and on the cytoplasmic side in bacteria .
Domain I has the binding site for NADq and NADH,
domain III for NADPq and NADPH. The very hy-
drophobic domain II spans the membrane. Informa-
tion on the structure of transhydrogenase is reviewed
w x4 .
Transhydrogenase from Rhodospirillum rubrum
has a unique subunit composition; domain I exists as
 .a separate polypeptide formerly called Th , whichs
can be removed by washing from everted membrane
 .vesicles chromatophores . The enzyme can be recon-
stituted with full recovery of activity by mixing the
domain I-depleted membranes, either with purified
w x w xnative 5 , or purified recombinant 6 , domain I
protein.
Although domain III in all known Hq-transhydro-
genases is on the same polypeptide as the
membrane-spanning domain II, water-soluble recom-
binant domain III of the R. rubrum enzyme was
prepared by incorporating a new start codon at the
w xappropriate position in the gene 7 . A mixture of
recombinant domain I and III proteins from R.
rubrum catalyses transhydrogenation reactions in the
w xabsence of the membrane-spanning domain II 7 .
The rates of ‘reverse’ and ‘forward’ transhydro-
 .genation Eqn. 1 catalysed by the complete, mem-
brane-bound enzyme from R. rubrum are limited by
slow release of product NADPq and NADPH, re-
w xspectively 8 . In mixtures of the domain IrIII pro-
teins, the rates of the reverse and forward transhydro-
 .genation reactions are even slower about 1000-fold
than in the complete enzyme because, in the absence
of domain II, the release of NADPq and NADPH are
w xretarded 7 .
Transhydrogenase will also perform a rapid ‘cyclic
q reaction’, the reduction of AcPdAD an analogue of
q. qNAD by NADH in the presence of either NADP
w x qor NADPH 9–13 : the NADPHrNADP remain
permanently bound to the domain III site of the
protein, and are alternately oxidized by AcPdADq
and then reduced by NADH in the domain I site
w x q11,12 . Because the binding of AcPdAD and
NADH, and the release of AcPdADH and NADq, are
relatively fast, the reaction is mainly limited by the
w xrate of hydride transfer between nucleotides 11,12 .
R. rubrum domain I:III complexes catalyse the cyclic
reaction at about the same rate as the complete
enzyme, indicating that the apparatus for the hydride
transfer step is located entirely within domains I and
w x qIII, and does not require domain II 7 . The NADP
and NADPH that are tightly bound to recombinant
domain III even after purification are sufficient to
support the cyclic reaction at high rates in the I:III
complexes.
The facility with which components of R. rubrum
transhydrogenase can be separated and recombined
with restoration of activity, promises to be valuable
in the study of the mechanism of action of the
enzyme. Parallel investigations of the forward, re-
verse and cyclic reactions are revealing because these
 .processes share some components hydride transfer
  . q .but not others NADP H release, H release , and
they are characterized by different rate-limiting steps.
This rationale was first used to establish that dicyclo-
hexylcarbodiimide treatment of purifed transhydro-
w xgenases from Rhodobacter capsulatus 14 and from
w x qE. coli 11 leads to a decrease in the rate of NADP
 .or proton release, but has little effect on the rate of
hydride transfer. Subsequently, a similar argument
was applied to mutants of the E. coli enzyme that
( )T. Bizouarn et al.rBiochimica et Biophysica Acta 1320 1997 265–274 267
were more inhibited in reverse, than in cyclic trans-
w xhydrogenation 15–17 . In this report we demonstrate
that mutations at Tyr-235 in the NMR-visible ‘mo-
w xbile loop’ region 18–20 of domain I of R. rubrum
.transhydrogenase fall into a different category.
Sequence comparisons show that the mobile loop
is a conserved feature in transhydrogenases but is
absent from alanine dehydrogenase, which is other-
w xwise very similar in sequence to domain I 5 . On the
basis of NMR experiments, it was proposed that the
loop closes down on the surface of domain I follow-
w xing the binding of NADH 18–20 . Tyr-235 is con-
served in all transhydrogenase sequences as part of a
short, Gly-Tyr-Ala motif, and at least in R. rubrum
domain I protein makes close contact with bound
w xnucleotide 19 . Substitution of Tyr-235 with either
Phe or Asn led to changes in the nucleotide binding
characteristics of the recombinant domain I protein,
but rates of reverse transhydrogenation in domain
I-depleted chromatophores reconstituted with mutant
proteins were only depressed by about 50% and 80%,
w xrespectively, relative to wild-type 20 . Light-driven
forward transhydrogenation rates in these reconsti-
tuted systems were inhibited only by about 60% and
80%, respectively. However, since forward and re-
verse transhydrogenation are limited by the rate of
product release, it was difficult, on the basis of those
observations, either to define the position of the
inhibited step, or to estimate the degree of inhibition
of that step. In this report an analysis of forward,
reverse and cyclic transhydrogenation in reconstituted
complete enzyme and in recombinant I:III complexes
shows that these mutations lead to specific and pro-
nounced inhibition of hydride transfer.
2. Materials and methods
R. rubrum wild-type strain S1, and the overex-
pressing strain, RTB2, were grown phototrophically,
and chromatophores, and chromatophores depleted of
w xdomain I protein were prepared as described 5,21 .
The bacteriochlorophyll content of these membranes
was assayed using the in vivo extinction coefficient
y1 y1 w xof 140 mM Pcm 22 .
The generation of the Tyr-235 mutants of the R.
rubrum transhydrogenase domain I protein dI.Y235F
. w xand dI.Y235N was described 7 . Recombinant do-
main I and domain III proteins from R. rubrum
 .transhydrogenase wild-type and mutants were ex-
pressed in E. coli, and purified by column chro-
w xmatography as described 6,7 , except that, following
a suggestion of Dr. Svetlana Sedenlikova of the
University of Sheffield, the Reactive Green 19 col-
umn used in the preparation of domain I protein was
replaced with a 6=3 cm column of Butyl Toyopearl
 .Tosohaas . The sample was loaded on to the column
in 10 mM Tris-HCl, pH 8.0, 1 mM dithiothreitol TD
.  .buffer plus 1.5 M NH SO , washed with 40 ml4 2 4
 .1.05 M NH SO in TD buffer, and eluted with a4 2 4
 .  .gradient 400 ml of 1.05 M to 0.6 M NH SO in4 2 4
TD buffer. A similar column was also included as the
last step in the preparation of domain III protein see
w x.7 . In this case the sample was loaded in 10 mM
 .Tris-HCl, pH 8.0, 10% glycerol TG buffer plus 0.41
 .M NH SO , and washed with 60 ml 0.41 M4 2 4
 .NH SO in TG buffer, then 40 ml 0.29 M4 2 4
 .NH SO in TG buffer, and eluted with a gradient4 2 4
 .  .400 ml of 0.29 M to 0.16 M NH SO in TG4 2 4
buffer. The proteins were more than 95% pure ac-
w xcording to analysis by SDS-PAGE 6,7 . Protein con-
centration was estimated by the microtannin proce-
w xdure 23 .
Reverse transhydrogenation the reduction of
q .AcPdAD by NADPH , forward transhydrogenation
 q .the reduction of thio-NADP by NADH and cyclic
 qtranshydrogenation reduction of AcPdAD by
NADH in the presence of added or endogenous
q .NADP or NADPH were measured as described
w x w x24 , using absorbance coefficients given 25 in the
conditions described in the figure legends.
Equilibrium dialysis was carried out using the
w x w xprocedures given 26 in the apparatus described 27 .
3. Results
3.1. The effect of mutation at Tyr-235 on the rate of
re˝erse and forward transhydrogenation
w xIn confirmation of earlier results 20 , when do-
main I-depleted chromatophores were reconstituted
with dI.Y235F or with dI.Y235N, the V of ‘re-max
 qverse transhydrogenation’ AcPdAD reduction by
.NADPH was decreased by about 50% and 78%,
respectively, relative to membranes reconstituted with
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Fig. 1. Reverse transhydrogenation in mixtures of recombinant
 .  .domain III protein plus wild-type domain I ^ or dI.Y235F v
 .or dI.Y235N ‘ . Experiments were performed in 50 mM Mops,
pH 7.2, 50 mM KCl, 2 mM MgCl , 200 mM NADPH and 2002
mM AcPdADq.
 .wild-type domain I results not shown . Note that the
rate of this reaction is mainly limited by the release
q w xof product NADP 8 .
Reverse transhydrogenation by a mixture of re-
combinant domain I and domain III proteins from R.
rubrum transhydrogenase is even more strongly rate
limited by the slow release of NADPq from domain
w xIII 7 . Fig. 1 shows that dI.Y235F and dI.Y235N in
mixtures with domain III protein catalyse AcPdADq
reduction by NADPH at steady-state rates that are
only slightly less than those with wild-type domain I.
The experiment was performed as a titration at fixed
domain III concentration and variable domain I
 .  w x.wild-type or mutant . The results show see 7 that
the reaction saturates when the domain I concentra-
tion is substantially less than that of domain III.
Relative to wild-type, only slightly more of the mu-
tant domain I proteins were needed to obtain satura-
tion.
The rate of ‘forward transhydrogenation’ reduc-
q .tion of thio-NADP by NADH by a mixture of
w xdomain I and III proteins is extremely slow 7 . It is
limited by the release of thio-NADPH from domain
III. Within experimental error the rates of forward
transhydrogenation in mixtures of domain III protein,
and either the wild-type or mutant domain I proteins
 .dI.Y235F and dI.Y235N were similar, at approxi-
mately 0.045 mol P moly1 domain III P miny1
 .saturated with the respective domain I — data not
shown.
3.2. Cyclic transhydrogenation as a measure of the
rate of the hydride transfer step
The rate of cyclic transhydrogenation is mainly
 .limited by hydride transfer see Section 1 . Thus, the
Fig. 2. The cyclic reaction catalysed by chromatophore trans-
hydrogenase is ‘ping-pong’ in NADH and AcPdADq. Domain
I-depleted chromatophore membranes from a transhydrogenase
 .over-expressing strain of R. rubrum see Section 2 were resus-
pended in 50 mM Mops, pH 7.0, 50 mM NaCl, 19 mM NADPq,
to a final bacteriochlorophyll of 0.7 mM, together with 33nM
recombinant domain I protein, at 308C. The other nucleotide
concentrations are given in the figure. The reaction was initiated
by addition of AcPdADq. A; fixed AcPdADq, variable NADH.
B: fixed NADH, variable AcPdADq.
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effects of mutagenesis on the rate of the cyclic
reaction should provide a good indication as to the
role of individual amino acid residues on the hydride
transfer step. A kinetic analysis of the nucleotide
substrate dependence of the cyclic reaction of wild-
type R. rubrum transhydrogenase has not previously
been presented, but is necessary to provide a basis for
understanding the effects of mutation. In Fig. 2 the
reactions were performed with domain I-depleted
chromatophore membranes reconstituted with wild-
type domain I — by carrying out appropriate controls
in the absence of domain I, we can ensure using this
Fig. 3. The effect of mutations at Tyr235 in domain I on the rate of cyclic transhydrogenation in reconstituted domain I-depleted
membranes. Experiments were performed as in Fig. 2, except that, for the wild-type, the domain I concentration was 30 nM and the
bacteriochlorophyll concentration of the depleted membranes was 0.3 mM. For the mutants, the domain I concentration was 90 nM and
the bacteriochlorophyll concentration of the depleted membranes was 3.2 mM. In all experiments, the concentration of NADPq was 25
q  .  . qmM. Top: fixed AcPdAD 200 mM , variable NADH. Bottom: fixed NADH 85 mM , variable AcPdAD . ^, wild-type domain I; v,
dI.Y235F; ‘, dI.Y235N.
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system, that AcPdADq reduction arises only from
proton-translocating transhydrogenase. The data are
presented as sr˝ against s plots of the dependence
of the rate of AcPdADq reduction by NADH, in the
q  .presence of NADP , A on the concentration of
NADH at different fixed concentrations of AcPdADq,
 . qand B on the concentration of AcPdAD at differ-
ent fixed concentrations of NADH. As was described
in detail for the detergent-dispersed E. coli enzyme,
the reaction is ‘ping-pong’ relative to AcPdADq and
NADH, with the two nucleotides competing for the
 .same binding site. Thus, a the curves converge at
 .sG0, and b high NADH concentrations give rise to
‘substrate inhibition’, indicated by the upward curva-
ture at high values of s. These observations confirm
that AcPdADq and NADH interact with the same
Fig. 4. The effect of mutations at Tyr235 in domain I on the nucleotide concentration dependence of the rate of cyclic transhydrogenation
 . in domain I:III complexes. Domain I protein 30 nM for wild-type, and 150 nM for the mutants plus domain III protein 4 nM when
.using wild-type domain I, and 39nM, when using mutant domain I were mixed in 50 mM NaCl, 50 mM Mops, pH 7.0. Top: fixed
q  .  . qAcPdAD 200 mM , variable NADH. Bottom: fixed NADH 85 mM , variable AcPdAD . ^, wild-type domain I; v, dI.Y235F; ‘,
dI.Y235N.
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site on the enzyme the nucleotide binding site on
. qdomain I , and that NADP and NADPH remain
tightly bound during the reaction the binary com-
plexes E.NADPq and E.NADPH remain stable dur-
ing turnover, the former being reduced by NADH,
q.and the latter being oxidized by AcPdAD . Sub-
strate inhibition at high concentrations of AcPdADq
was not evident from the data, presumably because
domain I binds this nucleotide rather more weakly
w xthan NADH 19,26 .
Fig. 3 compares the untransformed plots of sub-
strate dependences of the cyclic reaction as catalysed
by domain I-depleted chromatophores reconstituted
with wild-type domain I, with dI.Y235F and with
dI.Y235N. Fig. 4 shows the same but using mixtures
of domain III with wild-type domain I, with dI.Y235F
and with dI.Y235N. Note firstly, with respect to wild
type domain I, that the profiles of the data were
similar for both the complete enzyme and for the
domain I:III complex. This suggests that the nu-
cleotide-binding character of domain I is unaltered by
the presence of transmembrane domain II. We showed
previously that the absolute rates of the cyclic reac-
tion in the complete enzyme are similar to those in
w xthe I:III complex 7 . The k for the complex iscat
somewhat greater than 100 sy1 — the precise value
can not be estimated because of the substrate inhibi-
tion referred to above. Secondly, observe that the
mutant proteins had a similar effect on cyclic trans-
hydrogenation in the two systems. In both they
severely inhibited the cyclic reaction dI.Y235F by
.92–93%, and dI.Y235N by 97–98% , i.e., consider-
ably more than they inhibited forward and reverse
 .transhydrogenation see above . Despite the extensive
inhibition, for both the complete, membrane-bound
system and for the I:III complex, the nucleotide
concentration dependences were very similar with
wild-type domain I and with dI.Y235F and dI.Y235N.
This is reflected in the similar ‘K app’ and ‘K app’m i
 appvalues for the wild-type and mutants where ‘K ’ ism
the nucleotide concentration needed to give 50% of
the observed maximal rate and and ‘K app’ is thei
nucleotide concentration giving rise to 50% inhibi-
tion; the true Michaelis parameters are difficult to
determine because of the uncertainty in the value of
.k , and probably indicates that for both mutants,cat
the binding affinities for NADH and for AcPdADq
are decreased to a similar extent.
Fig. 5 shows the results of an experiment in which
cyclic transhydrogenation was measured as a function
of the concentration of domain I protein wild-type,
.dI.Y235F and dI.Y235N at a fixed concentration of
domain III note the differences in scale on the
. w xordinate . As noted 7 , and also in marked contrast to
the results on reverse transhydrogenation e.g., Fig.
.1 , the ratio of wild-type domain IrIII required for
Fig. 5. The effect of mutations at Tyr235 in domain I on the protein concentration dependence of the rate of cyclic transhydrogenation in
domain I:III complexes. Conditions as in Fig. 1, except that 200 mM NADH was present, and the NADPH concentration was 20 mM. ^,
wild-type; v, dI.Y235F; ‘, dI.Y235N. Note the difference in the scales for wild-type and mutants.
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Table 1
NADH binding affinities and stoichiometries of domain I pro-
teins
 .Domain I protein K mM Number of sitesd
Wild-type 30 1.1
dI.Y235F 65"11 1.0
dI.Y235N 116"15 1.2
Parameters were determined by equilibrium dialysis, as described
w xin 26 . Wild-type data are taken from that report.
half-saturation of the cyclic reaction was about one,
but, despite the strong inhibition of the rates of
reaction, that ratio was only slightly higher for the
two mutant domain I proteins.
3.3. Direct measurement of the nucleotide binding
affinity of domain I proteins carrying the mutations
Tyr-235“Phe and Tyr-235“Asn
Two sets of observations suggested that mutations
at Tyr-235 in the mobile loop region of domain I of
R. rubrum transhydrogenase result in a decreased
 .affinity of nucleotide binding. a NMR experiments
indicated that NADq exchanges more rapidly with
dI.Y235F and with dI.Y235N than with wild-type
w x  .protein 20 . b In a reconstituted system of recombi-
nant domain I protein plus domain I-depleted chro-
matophore membranes, the K for AcPdADq duringm
simple reverse transhydrogenation with NADPH was
substantially increased 10-fold for dI.Y235F, and
. w x13-fold for dI.Y235N 20 . Measurements of the
w xquenching of the fluorescence of Trp72 by NADH 6
were not sensitive enough to reveal differences in
nucleotide binding affinity of domain I protein. How-
ever, a decrease in the binding affinity for NADH
caused by mutations at Tyr-235 is now confirmed by
equilibrium dialysis measurements using a recently
 .published procedure Table 1 . The K increasedd
from approximately 30 mM in the wild type protein
to approximately 65 mM in dI.Y235F and 116 mM in
w x dI.Y235N. In wild-type 26 and both mutants Table
.1 the stoichiometry was consistent with one nu-
cleotide binding site per monomer.
4. Discussion
In this report the effects of substitution of Tyr-235
in the mobile loop of domain I of R. rubrum trans-
hydrogenase on several key reactions have been in-
vestigated. Substitutions of Tyr-235 with either Phe
or Asn had a more pronounced inhibitory effect on
reverse and forward transhydrogenation in the com-
plete enzyme, than they did in the domain I:III
complex. The rates of NADPq and NADPH release
are thought to be much slower, and thus contribute
more completely to rate limitation, in the I:III com-
w xplex than in the complete enzyme 7 . Thus, it may be
concluded that mutations at Tyr-235 have little effect
 .on NADP H release, or the associated
protonationrdeprotonation that accompany this pro-
cess.
In contrast, in both the complete reconstituted
enzyme, and in domain I:III complexes, cyclic trans-
hydrogenation was strongly inhibited by the muta-
 .tions. Because the binding and release of AcPdAD H
 . w x  .and NAD H are fast 19 , and because NADP H
remains bound to the protein during the cyclic reac-
w xtion 8,11,12 , it is likely that the hydride transfer
step is rate limiting. The strong inhibition of the
cyclic reaction in the Tyr-235 mutants is therefore
explained by the notion that their activities are
blocked either at the hydride transfer step or at an
associated conformational rearrangement.
In this context, it is also instructive to compare the
profiles of reverse and cyclic transhydrogenation in
the titrations of domain III protein with wild-type
domain I, with dI.Y235F and dI.Y235N Fig. 1 and
.  .Fig. 5 . 1 Although in measurements of the cyclic
reaction, the rates for the dI.Y235F and dI.Y235N
mutants were depressed by an order of magnitude or
 . more see above , the protein titration profiles rela-
.tive to the maximum rate at saturation were barely
 .changed from the wild-type Fig. 5 . This is consis-
w xtent with the argument 7 that the titration represents
the binding curve for the I:III complex the rate of
the cyclic reaction is proportional to the concentra-
.tion of the complex , and with the conclusion that
these amino acid substitutions do not affect the affin-
ity between domains I and III. From the data the Kd
values of the I:III complexes for the wild-type and
for the mutant domain I proteins are all in the range
 .30–50 nM. 2 It was noted that the titration profiles
of the wild-type IrIII proteins for reverse transhydro-
genation differ markedly from those for the cyclic
w xreaction 7 . Calculation shows that, during the re-
verse reaction, a single domain I protein can produc-
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tively visit about 60 domain III proteins during the
time taken for domain III to release NADPq, and this
is reflected in the fact that only a very small amount
of the domain I protein is required to saturate domain
 .III Fig. 1 . The estimated k value for the dissocia-off
y1 w xtion of the I:III complex is approximately 1.2 s 7 ,
much slower than the hydride transfer rate a little
y1 .more than 100 s , see above , and it is clear,
therefore, that the rate at which a wild-type domain I
protein can react with an NADPH-loaded domain III
protein depends more critically on the time taken for
the two proteins to dock and undock, than upon the
time of the hydride transfer reaction per se. This
explains why, for the dI.Y235F and dI.Y235N mu-
tants whose hydride transfer rates in the I:III com-
plex are decreased to approximately 7 sy1 and 2 sy1,
.respectively , the amounts of domain I protein re-
quired for half-saturation of domain III protein were
only slightly greater than the amount of wild-type
domain I needed for half-saturation. Thus, although
hydride transfer was strongly inhibited, its rate in the
mutants was depressed to a value which only just
approached the rate of the dockingrundocking pro-
cesses.
Parenthetically, it may be noted that, although
some of the component reactions in the process of
dockingrundocking in the I:III complex might occur
in the complete enzyme during turnover i.e., they
might represent catalytically important conforma-
.tional changes , it is evident from the above discus-
sion that, in its entirety, the process is too slow at
y1.around 1.2 s to be an intermediate in transhydro-
genation the k for reverse transhydrogenation wascat
around 27 sy1 for the complete R. rubrum enzyme
w x.7 . A similar conclusion was reached from observa-
tions on the rate of rebinding of isolated domain I to
depleted chromatophore membranes, a reaction which
w xproceeds on a time scale of a few seconds 28 .
The results of this analysis show that the con-
served Tyr at position 235 in the domain I protein of
R. rubrum transhydrogenase is important specifically
in the hydride transfer step of the enzyme, more
important than was thought on the basis of measure-
ments of forward and reverse transhydrogenation in
w xthe membrane-reconstituted system 20 . Substitution
with an Asn residue is more inhibitory than substitu-
tion with a Phe; it seems that retention of the aro-
matic character in the latter mutation reduces the
degree of inhibition. This Tyr is conserved in all
known transhydrogenase sequences, but though im-
portant, it is evidently not essential. The residue is
located in a segment of the domain I protein that is
highly mobile in the absence of nucleotide, but which
appears to close down and lose mobility as nucleotide
binds. NMR experiments show that, in the bound
state, Tyr-235 interacts with the adenosine moiety of
w xthe nucleotide 19 . The much decreased activities of
the dI.Y235F and dI.Y235N mutants, and their lower
 .affinities for NADH Table 1 , reinforces our view
w x18–20 that the ‘mobile loop’ has a function in
 .maintaining the NAD H in an appropriate hydropho-
bic environment and conformation in domain I to
 .effect the hydride transfer to or from the NADP H
bound in domain III.
Fluorosulphonylbenzoyladenosine reacted cova-
lently with Tyr-245 in mitochondrial transhydro-
genase equivalent to Tyr-235 of R. rubrum domain I
.protein , and caused pronounced inhibition of reverse
w xtranshydrogenation 29 . Different explanations for
this inhibition, and for the reported protection by
w xNADH, have been proposed 18,29,30 . Mutation of
the equivalent aTyr-226 in E. coli transhydrogenase
w xled to only 33–51% inhibition 30 . However, the
experiments with E. coli transhydrogenase were
 w x.probably performed under conditions see 11 in
which the release of NADPq partly limited the rates
of reaction. It is predicted from our experiments that
cyclic transhydrogenation by the E. coli aTyr-226
mutant enzymes will be considerably more inhibited
than the reverse reaction.
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